Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huixian Hu

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncology Reports|May 12, 2018
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)Wei He, Huixian Hu
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 21, 2015
Acquired coagulation factor XIII deficiency: a case reportYongqing Jia, Huixian Hu, Bin Wei
Annals of Medicine|March 13, 2023
Efficacy and safety of Venetoclax-based regimens in relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trialsWei He, Fang He, Huixian Hu
Clinical Laboratory|November 10, 2021
Regulation Effects of Circular RNA CircPVT1 and miR-125b on NF-κB Signal Pathway in Childhood ALLYongqing Jia, Huixian Hu, Weiying Gu
Hematology (Amsterdam, Netherlands)|December 15, 2020
Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysisWei He, Caifang Zhao, Huixian Hu
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|March 1, 2024
Clinical characteristics of hemophagocytic lymphohistiocytosisCancan Lu, Jimin Shi, Yamin Tan, et al.
Clinical Laboratory|June 13, 2024
Guillain-Barr Syndrome Caused by Cytomegalovirus after Multiple Myeloma TreatmentCancan Lu, Huixian Hu, Yishan Ye, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Zanubrutinib, Lenalidomide, and Rituximab Demonstrate Efficacy in Relapsed/Refractory Central Nervous System Lymphoma: A Single - Center Retrospective StudyJingcheng Zhang, Fang He, Yan Tu, et al.
Peerj|December 10, 2024
The epigenetic role of EZH2 in acute myeloid leukemiaJinyong Fang, Jingcheng Zhang, Lujian Zhu, et al.
Translational Cancer Research|July 11, 2024
Value analysis of <i>ITLN1</i> in the diagnostic and prognostic assessment of colorectal cancerYun Zhang, Tianyuan Gao, Min Wu, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncology Reports|May 12, 2018
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)Wei He, Huixian Hu
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 21, 2015
Acquired coagulation factor XIII deficiency: a case reportYongqing Jia, Huixian Hu, Bin Wei
Annals of Medicine|March 13, 2023
Efficacy and safety of Venetoclax-based regimens in relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trialsWei He, Fang He, Huixian Hu
Clinical Laboratory|November 10, 2021
Regulation Effects of Circular RNA CircPVT1 and miR-125b on NF-κB Signal Pathway in Childhood ALLYongqing Jia, Huixian Hu, Weiying Gu
Hematology (Amsterdam, Netherlands)|December 15, 2020
Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysisWei He, Caifang Zhao, Huixian Hu
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|March 1, 2024
Clinical characteristics of hemophagocytic lymphohistiocytosisCancan Lu, Jimin Shi, Yamin Tan, et al.
Clinical Laboratory|June 13, 2024
Guillain-Barr Syndrome Caused by Cytomegalovirus after Multiple Myeloma TreatmentCancan Lu, Huixian Hu, Yishan Ye, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Zanubrutinib, Lenalidomide, and Rituximab Demonstrate Efficacy in Relapsed/Refractory Central Nervous System Lymphoma: A Single - Center Retrospective StudyJingcheng Zhang, Fang He, Yan Tu, et al.
Peerj|December 10, 2024
The epigenetic role of EZH2 in acute myeloid leukemiaJinyong Fang, Jingcheng Zhang, Lujian Zhu, et al.
Translational Cancer Research|July 11, 2024
Value analysis of <i>ITLN1</i> in the diagnostic and prognostic assessment of colorectal cancerYun Zhang, Tianyuan Gao, Min Wu, et al.
Pageof 3